<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00216320</url>
  </required_header>
  <id_info>
    <org_study_id>WalkAide Trials</org_study_id>
    <nct_id>NCT00216320</nct_id>
  </id_info>
  <brief_title>Efficacy of the WalkAide and AFOs for CVA</brief_title>
  <official_title>A Three-Arm, Randomized Crossover Study Comparing the Innovative Neurotronics WalkAideâ„¢ System to Ankle-Foot Orthosis [AFO]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Innovative Neurotronics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Innovative Neurotronics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effectiveness of a new stimulator (WalkAide) for the treatment of foot drop.
      The comparison will involve physical measurements (e.g. walking speed, physiological cost
      index, Modified Rivermead Mobility Index, etc.) and questionnaires on the quality of life and
      acceptance of the technology by stroke survivors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the third leading cause of death in the United States and other developed countries
      and a major source of disability, often leading to hospitalization. Prognosis for regaining
      the ability to walk is good, with 64% of those initially dependent in walking regaining
      independence by three months. However, many gait abnormalities persist.

      Reduced hip, knee and ankle excursions during swing are among the persistent gait
      abnormalities contributing to poor or inefficient limb clearance. This is generally referred
      to as &quot;foot drop&quot;, since the foot drops or drags along the ground during the swing phase.
      Swing phase abnormalities can result in decreased velocity, limited endurance and an
      increased risk for falls. These factors can limit mobility and independence in the community.
      Therefore, intervention is warranted.

      The conventional approach to address the poor swing limb function, specifically, insufficient
      ankle dorsiflexion, is the prescription of an ankle-foot orthosis (AFO). An AFO commonly
      limits ankle plantarflexion to enhance limb clearance during swing. An alternative approach
      is to stimulate the ankle dorsiflexors electrically during swing phase to reproduce motion,
      which can no longer be performed volitionally.

      The WalkAide is a new foot drop stimulator. This small, self-contained device attaches to the
      leg below the knee. The WalkAide contains a number of patented features, including a tilt
      sensor that measures the orientation of the leg with respect to the vertical. When the leg is
      tilted back at the end of stance, stimulation of the common peroneal nerve is initiated. This
      produces flexion of the ankle and other joints (if a flexion reflex is elicited) so that the
      leg can clear the ground during swing. When the leg is tilted forward at the end of swing
      phase, the stimulus is terminated. The electrodes attach to the inside of a cuff that is
      molded to the leg for reproducible positioning from day to day. The device is also designed
      so that all operations can be done with a single hand, since hemiparesis may prevent the
      subject from using the other hand. Because of its enhanced features, the WalkAide is
      anticipated to increase walking speed and improve the quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Figure 8 Walking Speed Before and After Intervention.</measure>
    <time_frame>baseline, 6, 6.2 and 12 weeks</time_frame>
    <description>Subjects walked a 10 meter Figure 8 pattern for four minutes at fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physiological Cost Index Before and After Intervention.</measure>
    <time_frame>baseline, 6, 6.2 and 12 weeks</time_frame>
    <description>PCI is the difference between resting heart rate and active heart rate during walking, divided by average walking speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>10 Meter Walking Speed Before and After Intervention.</measure>
    <time_frame>baseline, 6, 6.2 and 12 weeks</time_frame>
    <description>Subjects walked 10 meters at their fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects Who Preferred Use of WalkAide Over the Use of AFO</measure>
    <time_frame>12 weeks</time_frame>
    <description>Subjects in Arm 1 or 2 (who used both devices) were given the option to continue using WalkAide or AFO for additional 12 weeks, their preference was recorded along with reasons for preference</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>WalkAide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects wear WalkAide for 6 weeks then cross over to AFO wear for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ankle Foot Orthosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear AFO for 6 weeks then cross over to WalkAide wear for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Crossover</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects wear AFO for entire 12 weeks with no crossover</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WalkAide</intervention_name>
    <description>Arm 1 - Subjects wear WalkAide for 6 weeks then cross over to AFO wear for 6 weeks</description>
    <arm_group_label>WalkAide</arm_group_label>
    <arm_group_label>Ankle Foot Orthosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AFO</intervention_name>
    <description>Arm 2 - Subjects wear AFO for 6 weeks then cross over to WalkAide wear for 6 weeks</description>
    <arm_group_label>WalkAide</arm_group_label>
    <arm_group_label>Ankle Foot Orthosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AFO</intervention_name>
    <description>Arm 3 - Subjects wear AFO for entire 12 weeks with no crossover</description>
    <arm_group_label>No Crossover</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adults aged 18 years or older

          2. Diagnosed with cerebrovascular accident (CVA) within the last 365 days

          3. Inadequate dorsiflexion during the swing phase of gait, resulting in inadequate limb
             clearance

          4. Medically stable for six months prior to the most recent episode of stroke resulting
             in hemiplegia or hemiparesis with foot drop

          5. Medical clearance by the attending physician to participate in the study

          6. Expectation that current medication can be maintained without drastic change for at
             least six months

          7. Adequate stability at the ankle during stance (with stimulation)

          8. Adequate cognitive and communication function to give informed consent, understand the
             training instructions, use the device and give adequate feedback

          9. Ability to ambulate with or without an assistive device (or assistance) at least 10
             meters

        Exclusion Criteria:

          1. Lower motor neuron injury with inadequate response to stimulation

          2. History of falls greater than once a week prior to the CVA

          3. Severe cardiac disease such as myocardial infarction, congestive heart failure or a
             demand pacemaker (or other electrical stimulator)

          4. Fixed ankle contractures of five degrees of plantarflexion with knee extended

          5. Moderate to normal ambulation velocity (greater than 1.2 m/s)

          6. Unable to operate the device safely by self and caregiver assistance not available

          7. Need for an AFO for stance control of the foot, ankle and/or knee

          8. Comorbid conditions unlikely to survive one year

          9. Pre-existing history of seizure disorder prior to most recent episode of CVA

         10. Pre-existing pathology resulting in a significant disruption in alignment or function
             of the lower extremity

         11. Morbid obesity that limits the subject's response to stimulation due to adipose tissue
             [BMI &gt; 40]

         12. Excessive dysesthetic pain secondary to neurological involvement

         13. Severe hypertonicity resulting in the need for more involved orthotic strategies or
             pharmacological interventions (e.g. Botox)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael C Munin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh, Department of PM&amp;R</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sunil Hegde, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huntington Rehabilitation Medicine Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerard Francisco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Institute of Rehabilitation Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Herman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Good Samaritan Rehabilitation Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thy Huskey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University in St. Louis, Department of Neurology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gary Abrams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California; San Francisco VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner Good Samaritan Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Francisco VA Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh, Department of PM&amp;R</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Institute of Rehabilitation Research</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Everaert DG, Stein RB, Abrams GM, Dromerick AW, Francisco GE, Hafner BJ, Huskey TN, Munin MC, Nolan KJ, Kufta CV. Effect of a foot-drop stimulator and ankle-foot orthosis on walking performance after stroke: a multicenter randomized controlled trial. Neurorehabil Neural Repair. 2013 Sep;27(7):579-91. doi: 10.1177/1545968313481278. Epub 2013 Apr 4.</citation>
    <PMID>23558080</PMID>
  </results_reference>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <results_first_submitted>April 18, 2013</results_first_submitted>
  <results_first_submitted_qc>April 18, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 19, 2013</results_first_posted>
  <last_update_submitted>April 18, 2013</last_update_submitted>
  <last_update_submitted_qc>April 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>electrical stimulation</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment took place between May 2005 and December 2008 at 9 Rehabilitation centers in the USA.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: WalkAide</title>
          <description>Subjects started with the WalkAide and crossed over to the AFO after six weeks.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: Ankle Foot Orthosis</title>
          <description>Subjects started with the AFO and crossed over to the WalkAide after six weeks.</description>
        </group>
        <group group_id="P3">
          <title>Arm 3: No Crossover</title>
          <description>Subjects completed the entire 12 weeks period with the AFO, no crossover occurred.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Phase 1 (Weeks 0 - 6)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Phase 2 (Weeks 6 -12)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1: WalkAide</title>
          <description>Subjects started with the WalkAide and crossed over to the AFO after six weeks.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: Ankle Foot Orthosis</title>
          <description>Subjects started with the AFO and crossed over to the WalkAide after six weeks.</description>
        </group>
        <group group_id="B3">
          <title>Arm 3: No Crossover</title>
          <description>Subjects completed the entire 12 weeks period with the AFO, no crossover occurred.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
            <count group_id="B2" value="39"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="112"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.1" spread="12.9"/>
                    <measurement group_id="B2" value="55.6" spread="11.9"/>
                    <measurement group_id="B3" value="58.8" spread="9.8"/>
                    <measurement group_id="B4" value="57.0" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronicity</title>
          <description>Chronicity refers to the number of years since onset of stroke</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.4" spread="3.8"/>
                    <measurement group_id="B2" value="6.9" spread="3.2"/>
                    <measurement group_id="B3" value="5.8" spread="3.7"/>
                    <measurement group_id="B4" value="6.4" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects Who Preferred Use of WalkAide Over the Use of AFO</title>
        <description>Subjects in Arm 1 or 2 (who used both devices) were given the option to continue using WalkAide or AFO for additional 12 weeks, their preference was recorded along with reasons for preference</description>
        <time_frame>12 weeks</time_frame>
        <population>per protocol (completers) analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Used Both WA and AFO</title>
            <description>Subjects in arm 1 (wore WalkAide for 6 weeks followed by AFO for 6 weeks) and arm 2 (wore AFO for 6 weeks followed by WalkAide for 6 weeks)were given the option of continuing for 12 more weeks with their choice of device</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Who Preferred Use of WalkAide Over the Use of AFO</title>
          <description>Subjects in Arm 1 or 2 (who used both devices) were given the option to continue using WalkAide or AFO for additional 12 weeks, their preference was recorded along with reasons for preference</description>
          <population>per protocol (completers) analysis</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Figure 8 Walking Speed Before and After Intervention.</title>
        <description>Subjects walked a 10 meter Figure 8 pattern for four minutes at fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
        <time_frame>baseline, 6, 6.2 and 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: WalkAide</title>
            <description>Subjects started with the WalkAide and crossed over to the AFO after six weeks.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Ankle Foot Orthosis</title>
            <description>Subjects started with the AFO and crossed over to the WalkAide after six weeks.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: No Crossover</title>
            <description>Subjects completed the entire 12 weeks period with the AFO, no crossover occurred.</description>
          </group>
        </group_list>
        <measure>
          <title>Figure 8 Walking Speed Before and After Intervention.</title>
          <description>Subjects walked a 10 meter Figure 8 pattern for four minutes at fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
          <units>meters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 0 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".337" spread=".164"/>
                    <measurement group_id="O2" value=".312" spread=".151"/>
                    <measurement group_id="O3" value=".261" spread=".182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".432" spread=".207"/>
                    <measurement group_id="O2" value=".377" spread=".166"/>
                    <measurement group_id="O3" value=".303" spread=".195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 0 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".358" spread=".157"/>
                    <measurement group_id="O2" value=".368" spread=".186"/>
                    <measurement group_id="O3" value=".331" spread=".203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".456" spread=".205"/>
                    <measurement group_id="O2" value=".428" spread=".179"/>
                    <measurement group_id="O3" value=".366" spread=".205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6.2 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".446" spread=".216"/>
                    <measurement group_id="O2" value=".383" spread=".162"/>
                    <measurement group_id="O3" value=".303" spread=".195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".467" spread=".233"/>
                    <measurement group_id="O2" value=".420" spread=".171"/>
                    <measurement group_id="O3" value=".328" spread=".212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6.2 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".471" spread=".219"/>
                    <measurement group_id="O2" value=".400" spread=".153"/>
                    <measurement group_id="O3" value=".366" spread=".205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".520" spread=".236"/>
                    <measurement group_id="O2" value=".436" spread=".172"/>
                    <measurement group_id="O3" value=".388" spread=".208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physiological Cost Index Before and After Intervention.</title>
        <description>PCI is the difference between resting heart rate and active heart rate during walking, divided by average walking speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
        <time_frame>baseline, 6, 6.2 and 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: WalkAide</title>
            <description>Subjects started with the WalkAide and crossed over to the AFO after six weeks.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Ankle Foot Orthosis</title>
            <description>Subjects started with the AFO and crossed over to the WalkAide after six weeks.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: No Crossover</title>
            <description>Subjects completed the entire 12 weeks period with the AFO, no crossover occurred.</description>
          </group>
        </group_list>
        <measure>
          <title>Physiological Cost Index Before and After Intervention.</title>
          <description>PCI is the difference between resting heart rate and active heart rate during walking, divided by average walking speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
          <units>beats/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 0 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".957" spread="0618"/>
                    <measurement group_id="O2" value="1.128" spread=".616"/>
                    <measurement group_id="O3" value="1.486" spread=".753"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".824" spread=".446"/>
                    <measurement group_id="O2" value=".978" spread=".698"/>
                    <measurement group_id="O3" value="1.311" spread=".720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 0 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".985" spread=".580"/>
                    <measurement group_id="O2" value=".903" spread=".440"/>
                    <measurement group_id="O3" value="1.163" spread=".621"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".791" spread=".411"/>
                    <measurement group_id="O2" value=".853" spread=".471"/>
                    <measurement group_id="O3" value="1.022" spread=".455"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6.2 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".796" spread=".484"/>
                    <measurement group_id="O2" value=".908" spread=".499"/>
                    <measurement group_id="O3" value="1.311" spread=".720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".712" spread=".494"/>
                    <measurement group_id="O2" value=".983" spread=".662"/>
                    <measurement group_id="O3" value="1.160" spread=".823"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6.2 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".726" spread=".435"/>
                    <measurement group_id="O2" value=".847" spread=".400"/>
                    <measurement group_id="O3" value="1.022" spread=".455"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".656" spread=".325"/>
                    <measurement group_id="O2" value=".972" spread=".694"/>
                    <measurement group_id="O3" value=".892" spread=".481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>10 Meter Walking Speed Before and After Intervention.</title>
        <description>Subjects walked 10 meters at their fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
        <time_frame>baseline, 6, 6.2 and 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: WalkAide</title>
            <description>Subjects started with the WalkAide and crossed over to the AFO after six weeks.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Ankle Foot Orthosis</title>
            <description>Subjects started with the AFO and crossed over to the WalkAide after six weeks.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: No Crossover</title>
            <description>Subjects completed the entire 12 weeks period with the AFO, no crossover occurred.</description>
          </group>
        </group_list>
        <measure>
          <title>10 Meter Walking Speed Before and After Intervention.</title>
          <description>Subjects walked 10 meters at their fastest safe speed. This was measured under two conditions: On condition - the WA turned on or the AFO worn by the subject; off condition - The WA turned off or the AFO not worn by the subject. The endpoints were analyzed at 6, and 12 weeks</description>
          <units>meters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 0 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".457" spread=".245"/>
                    <measurement group_id="O2" value=".415" spread=".220"/>
                    <measurement group_id="O3" value=".361" spread=".264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".575" spread=".291"/>
                    <measurement group_id="O2" value=".489" spread=".233"/>
                    <measurement group_id="O3" value=".428" spread=".286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 0 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".524" spread=".253"/>
                    <measurement group_id="O2" value=".472" spread=".246"/>
                    <measurement group_id="O3" value=".438" spread=".286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".625" spread=".309"/>
                    <measurement group_id="O2" value=".568" spread=".261"/>
                    <measurement group_id="O3" value=".500" spread=".308"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6.2 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".591" spread=".304"/>
                    <measurement group_id="O2" value=".486" spread=".229"/>
                    <measurement group_id="O3" value=".428" spread=".286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12 off condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".641" spread=".349"/>
                    <measurement group_id="O2" value=".564" spread=".264"/>
                    <measurement group_id="O3" value=".477" spread=".296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6.2 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".645" spread=".313"/>
                    <measurement group_id="O2" value=".508" spread=".223"/>
                    <measurement group_id="O3" value=".500" spread=".308"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12 on condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".730" spread=".369"/>
                    <measurement group_id="O2" value=".596" spread=".278"/>
                    <measurement group_id="O3" value=".546" spread=".326"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>All subjects used WalkAide for the first 6 weeks and AFO for the second six weeks.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>All subjects used AFO for the first 6 weeks and WalkAide for the second six weeks.</description>
        </group>
        <group group_id="E3">
          <title>Arm 3</title>
          <description>All subjects used AFO for all 12 weeks of study.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart surgery</sub_title>
                <description>Had emergency heart surgery 9/15/06</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>began experiencing symptoms, went to ER and was admitted for an acute MI. Patient was discharged from the hospital and scheduled for heart surgery to remove blockage. However he then passed away suddenly, before the surgery was done</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <description>Pt fell and fractured wrist. Subject was in teh AFO phase of Arm @ but was not wearing a study device at the time</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Lost consciousness</sub_title>
                <description>Pt lost consciousness in Physical Therapy, no reason was reported</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>weakness and fatigue</sub_title>
                <description>Subject was weak and fatigued, required bedrest</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <description>tripped and fell</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="39"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Ankle sprain</sub_title>
                <description>sprained ankle getting out of bed</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>LE swelling</sub_title>
                <description>Subject complained of swelling not previously noted</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Shoulder surgery</sub_title>
                <description>Subject had surgery for rotator cuff tear</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus condition</sub_title>
                <description>subject missed visit due to sinus infection</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin Irritation electrodes</sub_title>
                <description>Irritation from electrodes used with WalkAide</description>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="43"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Skin irritation AFO</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Research</name_or_title>
      <organization>Innovative Neurotronics</organization>
      <phone>512-721-1922</phone>
      <email>hrogers@ininc.us</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

